PL1735347T3 - Specyficznie wiążące cząsteczki przeciwko synaptofizynie - Google Patents

Specyficznie wiążące cząsteczki przeciwko synaptofizynie

Info

Publication number
PL1735347T3
PL1735347T3 PL05729772T PL05729772T PL1735347T3 PL 1735347 T3 PL1735347 T3 PL 1735347T3 PL 05729772 T PL05729772 T PL 05729772T PL 05729772 T PL05729772 T PL 05729772T PL 1735347 T3 PL1735347 T3 PL 1735347T3
Authority
PL
Poland
Prior art keywords
specific binding
binding molecules
molecules against
against synaptophysin
synaptophysin
Prior art date
Application number
PL05729772T
Other languages
English (en)
Inventor
Matthew Wright
Andy Porter
Original Assignee
The Univ Court Of The Univ Of Aberdeen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0407059A external-priority patent/GB0407059D0/en
Priority claimed from GB0416402A external-priority patent/GB0416402D0/en
Application filed by The Univ Court Of The Univ Of Aberdeen filed Critical The Univ Court Of The Univ Of Aberdeen
Publication of PL1735347T3 publication Critical patent/PL1735347T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/08—Hepato-biliairy disorders other than hepatitis
    • G01N2800/085—Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL05729772T 2004-03-29 2005-03-29 Specyficznie wiążące cząsteczki przeciwko synaptofizynie PL1735347T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0407059A GB0407059D0 (en) 2004-03-29 2004-03-29 Specific binding members against synaptophysin
GB0416402A GB0416402D0 (en) 2004-07-22 2004-07-22 Specific binding members against synaptophysin
EP05729772A EP1735347B1 (en) 2004-03-29 2005-03-29 Specific binding molecules against synaptophysin
PCT/GB2005/001190 WO2005095453A2 (en) 2004-03-29 2005-03-29 Specific binding members against synaptophysin

Publications (1)

Publication Number Publication Date
PL1735347T3 true PL1735347T3 (pl) 2013-04-30

Family

ID=35064446

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05729772T PL1735347T3 (pl) 2004-03-29 2005-03-29 Specyficznie wiążące cząsteczki przeciwko synaptofizynie

Country Status (8)

Country Link
US (2) US7871782B2 (pl)
EP (1) EP1735347B1 (pl)
JP (2) JP5020808B2 (pl)
KR (1) KR101205655B1 (pl)
CN (1) CN103130895A (pl)
CA (1) CA2584608C (pl)
PL (1) PL1735347T3 (pl)
WO (1) WO2005095453A2 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7871782B2 (en) * 2004-03-29 2011-01-18 The University Court Of The University Of Aberdeen Specific binding members against synaptophysin
EP2699603B1 (en) 2011-04-19 2016-03-02 The United States of America As Represented by the Secretary Department of Health and Human Services Human monoclonal antibodies specific for glypican-3 and use thereof
KR102006997B1 (ko) * 2012-07-03 2019-08-02 한국생명공학연구원 ＩｇＧ Ｆｃ 위치선택적 결합 펩티드 및 이를 포함하는 하이브리드 분자
SI2906597T1 (sl) * 2012-10-15 2020-08-31 Medimmune Limited Protitelesa za amiloid beta
WO2023210585A1 (ja) * 2022-04-25 2023-11-02 株式会社Jiksak Bioengineering 標的化剤
WO2024055010A1 (en) * 2022-09-08 2024-03-14 Board Of Regents, The University Of Texas System Compositions for treating cancer and methods of using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3940209A1 (de) * 1989-12-05 1991-06-06 Boehringer Mannheim Gmbh Verfahren zum nachweis eines kleinzelligen bronchial-karzinoms
US5859205A (en) * 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
EP0528663B1 (en) * 1991-08-16 1997-10-29 Kabushiki Kaisha Toshiba Monoclonal antibody to a synaptophysin
GB9722131D0 (en) * 1997-10-20 1997-12-17 Medical Res Council Method
CA2375033A1 (en) * 1999-05-27 2000-12-07 Max-Delbruck-Centrum Fur Molekulare Medizin Vaccines against conformation-dependent antigens and against antigens that are not or are not only proteins or peptides
EP1531825A2 (en) * 2002-08-29 2005-05-25 University Of Southampton Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases
US7871782B2 (en) * 2004-03-29 2011-01-18 The University Court Of The University Of Aberdeen Specific binding members against synaptophysin

Also Published As

Publication number Publication date
EP1735347B1 (en) 2012-11-07
WO2005095453B1 (en) 2006-12-21
US20080274123A1 (en) 2008-11-06
US7871782B2 (en) 2011-01-18
EP1735347A2 (en) 2006-12-27
CN103130895A (zh) 2013-06-05
JP2012162551A (ja) 2012-08-30
JP2008506358A (ja) 2008-03-06
JP5020808B2 (ja) 2012-09-05
CA2584608A1 (en) 2005-10-13
KR20060135046A (ko) 2006-12-28
WO2005095453A2 (en) 2005-10-13
US20110165078A1 (en) 2011-07-07
CA2584608C (en) 2015-03-17
KR101205655B1 (ko) 2012-12-13
WO2005095453A3 (en) 2006-04-06

Similar Documents

Publication Publication Date Title
ZA201301416B (en) Binding molecules
IL184467A0 (en) Cripto binding molecules
ZA200806492B (en) Binding molecules
GB0621973D0 (en) Binding molecules and uses thereof
EP1827245A4 (en) BINDING COMPONENT
EP1907001A4 (en) ILT3 BONDING MOLECULES AND ITS USES
GB0521991D0 (en) Siglec-9 binding agents
GB0510790D0 (en) Anti-CD16 binding molecules
GB0618345D0 (en) Binding molecules
IL182279A0 (en) Angiopoietin-2-specific binding agents
EP1710096A4 (en) BINDING DEVICE
GB0404187D0 (en) Binding agents
PL1735347T3 (pl) Specyficznie wiążące cząsteczki przeciwko synaptofizynie
EP1966603A4 (en) FIXING MOLECULES
GB0601511D0 (en) Binding Molecules 2
GB0520523D0 (en) Object binding
EP1932681A4 (en) BINDER
GB0410983D0 (en) Molecules
GB0410627D0 (en) Specific binding members
GB0406342D0 (en) Molecules
GB0407059D0 (en) Specific binding members against synaptophysin
GB0416402D0 (en) Specific binding members against synaptophysin
GB0511881D0 (en) Binding molecules
GB0522320D0 (en) Binding apparatus
GB2422575B (en) Files